Filing metadata

Accession number
0001562180-24-005021
Form type
Form 4
Filer
Edgewise Therapeutics, Inc.
CIK
CIK 1710072
Filed
Jun 12, 2024
Reporting period
Jun 10, 2024
Description
Insider transaction

Explore SEC Filings Hub